Related Experiment Video

Updated: Jun 8, 2026

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
10:30

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7

Christina Kittipatarin1, Wenqing Li, Scott K Durum

  • 1Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Boulevard, Orlando, FL 32827, USA.

Experimental Hematology
|September 14, 2010
PubMed

Insights

Interleukin-7 (IL-7) drives T-cell proliferation via Cdc25A, inhibiting Foxo1 nuclear translocation. This reduces CD62L expression, promoting T-cell circulation and impacting lymphocyte movement.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Interleukin-7 (IL-7) is a cytokine with immunotherapeutic potential.
  • High doses of IL-7 can cause transient T-cell depletion.
  • The mechanism linking IL-7 signaling to lymphocyte motility requires elucidation.

Purpose of the Study:

  • Investigate how IL-7 signaling, through Cdc25A, influences lymphocyte movement.
  • Determine the role of Cdc25A in IL-7-induced T-cell proliferation and activation.
  • Elucidate the impact of IL-7 on T-cell homing and circulation.

Main Methods:

  • Manipulated Cdc25A gene expression using novel techniques.
  • Evaluated IL-7 effects in vitro and in vivo.
  • Assessed expression of activation (CD69, CD44) and homing (CD62L) markers.
  • Tracked nuclear translocation of transcription factor Foxo1.

Main Results:

  • Constitutive Cdc25A activity induced T-cell proliferation and activation markers independent of IL-7.
  • Cdc25A inhibition decreased proliferation, reduced activation markers, and increased CD62L expression.
  • IL-7 prevented Foxo1 nuclear translocation in a Cdc25A-dependent manner, decreasing CD62L.
  • In vivo IL-7 administration reduced lymph node cellularity; IL-7 + M25 increased it with more nuclear Foxo1.

Conclusions:

  • IL-7 promotes Cdc25A-mediated T-cell proliferation.
  • This process inhibits Foxo1 nuclear translocation.
  • Reduced Foxo1 nuclear translocation leads to decreased CD62L expression and T-cell migration into circulation.
Abstract

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Isolation and Activation of Murine Lymphocytes08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...